Non-communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Shiraz University of Medical Sciences, Shiraz, Iran.
Arch Iran Med. 2022 Jul 1;25(7):417-421. doi: 10.34172/aim.2022.69.
Hypothyroidism is the most common hormonal deficiency worldwide; however, there is limited data about its prevalence in the children and adolescents of the Middle East.
The prevalence of hypothyroidism were calculated by dividing the number of patients purchasing levothyroxine in 1397 Solar-Hijri year (Correlate with March 2018-February 2019) by the population at risk (per 10000 persons). Data were collected from the Iran health insurance organization registration records and family physician databases of health vice-chancellor of Shiraz University of Medical Sciences.
The present study shows that the prevalence of levothyroxine treated population aged under 18 years is 13 in 10000 in the Fars province and it is more common in females (17 in 10000 in females versus 9 in 10000 in males). This study also revealed that the prevalence of hypothyroidism was different in various age groups and increased in older children and adolescents after pubertal ages. Also, an increase in the female: male ratio of prevalence was more obvious during and after puberty.
Our study showed that the prevalence of congenital hypothyroidism was 3/10000 in southern Iran. Also, the prevalence of hypothyroidism in children and adolescents was totally 13/10000 population, and this prevalence increased in older age and female gender. This prevalence was close to the data from iodine sufficient areas in Europe and the United States.
甲状腺功能减退症是全球最常见的激素缺乏症;然而,关于其在中东地区儿童和青少年中的流行情况的数据有限。
通过将在 1397 太阳历-伊斯兰历(相当于 2018 年 3 月至 2019 年 2 月)期间购买左甲状腺素的患者人数除以风险人群(每 10000 人),计算出甲状腺功能减退症的患病率。数据来自伊朗健康保险组织的登记记录和 Shiraz 医科大学卫生副校长的家庭医生数据库。
本研究表明,法尔斯省 18 岁以下接受左甲状腺素治疗的人群患病率为 13/10000,女性更为常见(女性为 17/10000,男性为 9/10000)。本研究还表明,甲状腺功能减退症的患病率在不同年龄组之间存在差异,并在青春期后儿童和青少年中增加。此外,在青春期和青春期后,女性患病率与男性患病率的比例增加更为明显。
我们的研究表明,伊朗南部先天性甲状腺功能减退症的患病率为 3/10000。此外,儿童和青少年甲状腺功能减退症的总患病率为 13/10000 人口,且在年龄较大和女性中患病率增加。这一患病率与欧洲和美国碘充足地区的数据相近。